am 251 has been researched along with Colonic Neoplasms in 2 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
Colonic Neoplasms: Tumors or cancer of the COLON.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sreevalsan, S | 1 |
| Safe, S | 1 |
| Gustafsson, SB | 1 |
| Lindgren, T | 1 |
| Jonsson, M | 1 |
| Jacobsson, SO | 1 |
2 other studies available for am 251 and Colonic Neoplasms
| Article | Year |
|---|---|
The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells.
Topics: Benzoxazines; Cannabinoid Receptor Antagonists; Cell Line, Tumor; Cell Proliferation; Cell Survival; | 2013 |
Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antioxidants; Cannabinoid Receptor Antagonists; Can | 2009 |